Effects of mixed extracts of Drynaria fortunei rhizomes and Eleutherococus senticosus leaves on cognitive functions and stress in healthy adults

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2019
INTERVENTION: Tretament test drug: Intake of capsules containing two extracts of Drynaria fortunei rhizomes (20 mg/capsule) and Eleutherococus senticosus leavesas (200 mg/capsule), three capsules per day, for 12 weeks. Treatment placebo:Intake of capsules without two etracts, three capsules per day, for 12 weeks. CONDITION: Healthy adults PRIMARY OUTCOME: RBANS‐J for cognition, Public Health Research Foundation Stress Check List Short Form for anti‐stress, before and 12 weeks after the intake. SECONDARY OUTCOME: JART, MMSE‐J for cognition, before and 12 weeks after the intake. INCLUSION CRITERIA:
Epistemonikos ID: bbd980e31267973403cb9d4249cd6a849ea44b42
First added on: Aug 24, 2024